Ferric carboxymaltose for treatment of iron deficiency and iron deficiency anemia caused by abnormal uterine bleeding

INTRODUCTION: Heavy menstrual bleeding leads to depletion of iron stores, with subsequent iron deficiency (ID) and iron deficiency anemia (IDA). To evaluate the efficacy and safety of ferric carboxymaltose (FCM) in treatment of ID/IDA caused by abnormal uterine bleeding (AUB). MATERIAL AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagras, Ahmed M., Hussein, Naglaa Ali, Abdelazim, Ibrahim, Elhamamy, Nareman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871999/
https://www.ncbi.nlm.nih.gov/pubmed/36704761
http://dx.doi.org/10.5114/pm.2022.124013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871999/
https://www.ncbi.nlm.nih.gov/pubmed/36704761
http://dx.doi.org/10.5114/pm.2022.124013

Ejemplares similares